How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

• Bente Glintborg,
• Johan Askling,
• Katerina Chatzidionysiou,
• Lene Dreyer,
• Thomas Frisell,
• Kalle Aaltonen,
• Bénédicte Delcoigne,
• Merete L Hetland,
• René Cordtz,
• Kristian Zobbe,
• Nina Trokovic,
• Sella Aarrestad Provan

Affiliations

Bente Glintborg

1 The DANBIO registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet Glostrup, Glostrup, Denmark

Johan Askling

Division of Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Katerina Chatzidionysiou

st Department of Propaedeutic and Internal Medicine, Joint Rheumatology Program, Laiko Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece

Lene Dreyer

Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark

Thomas Frisell

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska Institutet Department of Medicine Solna, Stockholm, Sweden

Kalle Aaltonen

Pharmaceuticals Pricing Board, Ministry of Social Affairs and Health, Helsinki, Finland

Bénédicte Delcoigne

Division of Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Merete L Hetland

DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet, Copenhagen, Denmark

René Cordtz

Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte Hospital, The Parker Institute, Frederiksberg Hospital Parker Institute, Frederiksberg, Denmark

Kristian Zobbe

Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte Hospital, The Parker Institute, Frederiksberg Hospital Parker Institute, Frederiksberg, Denmark

Nina Trokovic

Helsinki University and Hospital (ROB-FIN), Departments of Medicine and Rheumatology, Helsinki University Central Hospital, Helsinki, Finland

Sella Aarrestad Provan

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway